Pharma Innovation, Powered by AI
Key insights from the report:
1. Pharma AI Partnership Growth:
Between 2018 and 2023, partnerships surged by 3.9 times, shifting focus towards Research Solutions. With 76% adoption, AI and Generative AI enhance productivity.2. Shift in Focus:
Initially, partnerships predominantly centred around Patient Solutions and Medical Diagnostics (accounting for 45% in 2018). However, by 2023, the focus shifted significantly toward Research Solutions, constituting 32% of partnerships. This strategic shift has led to enhanced clinical development productivity.3. AI Implementation:
To further boost productivity, ventures are increasingly adopting Artificial Intelligence (AI) and Generative AI solutions. In Research Solutions, 76% of ventures utilize AI and GenAI.4. Top Biopharma Players:
The top 20 Biopharma companies (based on 2022 sales) account for 40% of all partnerships in this sector. The remaining 60% of partnerships are distributed among over 350 other Biopharma companies.5. Venture Maturity:
Ventures have progressed beyond prototypes and proof-of-concept (POC) stages. In the Research Solutions domain, 44% of ventures exhibit Clinical Strength (Evidence Signal > 40). Clinical Strength underscores the tangible impact of a venture’s Digital Health solution on patient outcomes.
6. Funding Landscape:
Financial pressure remains high in the Digital Health ecosystem. Globally, among Research Solutions ventures, only a third or fewer of Growth-Stage ventures in North America and Asia Pacific have secured funding in the past 18 months, indicating relatively weak funding strength. In contrast, 75% of European-founded ventures have successfully raised funding.Featured companies in the Pharma Innovation, Powered by AI Report
- Digital Health ventures featured in this report: myNEO Therapeutics, Concr, VantAI, Known Medicine, Epigene Labs, Kaiko, OneThree Biotech, ADLIN Science, Geneyx (ג'ניקס ג'נומיקס בעמ)", Epistra (エピストラ), Unlearn, InSilicoTrials, Novadiscovery, Elucidata, Verge Genomics, ConcertAI, Exscientia, Fauna Bio, Relation Therapeutics, Generate: Biomedicines, Seismic Therapeutic, BioAge Labs, Atomic AI, PhenomicAI, XtalPi (晶泰科技), Genesis Therapeutics, Saluda Medical, Harbinger Health, Inceptive, Alentis Therapeutics, Modulus Discovery, Aqemia, Chroma Medicine, Metagenomi, Congenica, Flywheel, Twin Health, Reverie Labs, Orbital Therapeutics, Scailyte, Recursion, Alto Neurosciences, Neumora Therapeutics, Turnstone Biologics, Bullfrog AI, One Biosciences, basgenbio (바스젠바이오), Caris Life Sciences, Verge Genomics, Perlara